Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The FOUNDATION Study: Hospital Formulation Of B. Infantis EVC001 Utilized In The NICU To Demonstrate Tolerability In The Investigator's Preterm Neonates

NCT03939546 is registered in ClinicalTrials.gov with Evolve BioSystems, Inc. as lead sponsor.

NCT NCT03939546
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03939546 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The FOUNDATION Study: Hospital Formulation Of B. Infantis EVC001 Utilized In The NICU To Demonstrate Tolerability In The Investigator's Preterm Neonates
Lead sponsor
Evolve BioSystems, Inc.
Phase
Not applicable
Overall status
Completed
Start date
July 3, 2019
Completion date
June 1, 2021
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

preterm infant